229 related articles for article (PubMed ID: 7799165)
21. Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor.
Kieft R; Capewell P; Turner CM; Veitch NJ; MacLeod A; Hajduk S
Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16137-41. PubMed ID: 20805508
[TBL] [Abstract][Full Text] [Related]
22. African trypanosomes: intracellular trafficking of host defense molecules.
Shiflett AM; Faulkner SD; Cotlin LF; Widener J; Stephens N; Hajduk SL
J Eukaryot Microbiol; 2007; 54(1):18-21. PubMed ID: 17300512
[TBL] [Abstract][Full Text] [Related]
23. Variant surface glycoprotein from Trypanosoma evansi is partially responsible for the cross-reaction between Trypanosoma evansi and Trypanosoma vivax.
Uzcanga GL; Perrone T; Noda JA; Pérez-Pazos J; Medina R; Hoebeke J; Bubis J
Biochemistry; 2004 Jan; 43(3):595-606. PubMed ID: 14730963
[TBL] [Abstract][Full Text] [Related]
24. Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.
Baral TN; Magez S; Stijlemans B; Conrath K; Vanhollebeke B; Pays E; Muyldermans S; De Baetselier P
Nat Med; 2006 May; 12(5):580-4. PubMed ID: 16604085
[TBL] [Abstract][Full Text] [Related]
25. A receptor-like flagellar pocket glycoprotein specific to Trypanosoma brucei gambiense.
Berberof M; Pérez-Morga D; Pays E
Mol Biochem Parasitol; 2001 Mar; 113(1):127-38. PubMed ID: 11254961
[TBL] [Abstract][Full Text] [Related]
26. Resistance to the African trypanosomes is IFN-gamma dependent.
Hertz CJ; Filutowicz H; Mansfield JM
J Immunol; 1998 Dec; 161(12):6775-83. PubMed ID: 9862708
[TBL] [Abstract][Full Text] [Related]
27. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
Gehrig S; Efferth T
Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
[TBL] [Abstract][Full Text] [Related]
28. Expression and localization of serum resistance associated protein in Trypanosoma brucei rhodesiense.
Milner JD; Hajduk SL
Mol Biochem Parasitol; 1999 Nov; 104(2):271-83. PubMed ID: 10593181
[TBL] [Abstract][Full Text] [Related]
29. Effects of heparin administration on Trypanosoma brucei gambiense infection in rats.
Nishimura K; Shima K; Asakura M; Ohnishi Y; Yamasaki S
J Parasitol; 2005 Feb; 91(1):219-22. PubMed ID: 15856910
[TBL] [Abstract][Full Text] [Related]
30. Structure of the trypanosome haptoglobin-hemoglobin receptor and implications for nutrient uptake and innate immunity.
Higgins MK; Tkachenko O; Brown A; Reed J; Raper J; Carrington M
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1905-10. PubMed ID: 23319650
[TBL] [Abstract][Full Text] [Related]
31. Trypanosoma congolense bloodstream forms evade complement lysis in vitro by shedding of immune complexes.
Frevert U; Reinwald E
Eur J Cell Biol; 1990 Aug; 52(2):264-9. PubMed ID: 2081529
[TBL] [Abstract][Full Text] [Related]
32. The human trypanolytic factor: a drug shaped naturally.
Vanhamme L
Infect Disord Drug Targets; 2010 Aug; 10(4):266-82. PubMed ID: 20429865
[TBL] [Abstract][Full Text] [Related]
33. The lysis of Trypanosoma brucei brucei by human serum.
Tomlinson S; Raper J
Nat Biotechnol; 1996 Jun; 14(6):717-21. PubMed ID: 9630977
[TBL] [Abstract][Full Text] [Related]
34. [Human resistance to African trypanosoma infections].
Perez-Morga D
Bull Mem Acad R Med Belg; 2007; 162(7-9):381-6; discussion 386. PubMed ID: 18429487
[TBL] [Abstract][Full Text] [Related]
35. Human macrophage tumor necrosis factor (TNF)-alpha production induced by Trypanosoma brucei gambiense and the role of TNF-alpha in parasite control.
Daulouède S; Bouteille B; Moynet D; De Baetselier P; Courtois P; Lemesre JL; Buguet A; Cespuglio R; Vincendeau P
J Infect Dis; 2001 Mar; 183(6):988-91. PubMed ID: 11237819
[TBL] [Abstract][Full Text] [Related]
36. Control of parasitemia and survival during Trypanosoma brucei brucei infection is related to strain-dependent ability to produce IL-4.
Bakhiet M; Jansson L; Büscher P; Holmdahl R; Kristensson K; Olsson T
J Immunol; 1996 Oct; 157(8):3518-26. PubMed ID: 8871651
[TBL] [Abstract][Full Text] [Related]
37. The role of transferrin-receptor variation in the host range of Trypanosoma brucei.
Bitter W; Gerrits H; Kieft R; Borst P
Nature; 1998 Jan; 391(6666):499-502. PubMed ID: 9461219
[TBL] [Abstract][Full Text] [Related]
38. Contribution of the complement system to antibody-mediated binding of Trypanosoma gambiense to macrophages.
Takayanagi T; Kawaguchi H; Yabu Y; Itoh M; Appawu MA
J Parasitol; 1987 Apr; 73(2):333-41. PubMed ID: 3585629
[TBL] [Abstract][Full Text] [Related]
39. Haptoglobin-hemoglobin receptor independent killing of African trypanosomes by human serum and trypanosome lytic factors.
Bullard W; Kieft R; Capewell P; Veitch NJ; Macleod A; Hajduk SL
Virulence; 2012; 3(1):72-6. PubMed ID: 22286709
[TBL] [Abstract][Full Text] [Related]
40. The identification of Trypanosoma brucei gambiense in Liberian pigs and dogs by isoenzymes and by resistance to human plasma.
Gibson W; Mehlitz D; Lanham SM; Godfrey DG
Tropenmed Parasitol; 1978 Sep; 29(3):335-45. PubMed ID: 726046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
